Trending Stock News

Exact Sciences (EXAS) Holder Palo Alto Investors Has Decreased Stake by $6.35 Million; Glacier Peak Capital Position in Loral Space & Communications (LORL) Has Decreased by $3.78 Million as Stock Value Declined

Exact Sciences Corporation (NASDAQ:EXAS) Logo

Glacier Peak Capital Llc decreased its stake in Loral Space & Communications (LORL) by 57.46% based on its latest 2017Q4 regulatory filing with the SEC. Glacier Peak Capital Llc sold 77,041 shares as the company’s stock declined 4.19% with the market. The hedge fund held 57,031 shares of the technology company at the end of 2017Q4, valued at $2.82M, down from 134,072 at the end of the previous reported quarter. Glacier Peak Capital Llc who had been investing in Loral Space & Communications for a number of months, seems to be less bullish one the $1.23 billion market cap company. The stock increased 0.13% or $0.05 during the last trading session, reaching $39.6. About 13,840 shares traded. Loral Space & Communications Inc. (NASDAQ:LORL) has risen 7.35% since May 23, 2017 and is uptrending. It has underperformed by 4.20% the S&P500.

William Leland Edwards decreased its stake in Exact Sciences Corp (EXAS) by 28.22% based on its latest 2017Q4 regulatory filing with the SEC. Palo Alto Investors Llc sold 122,200 shares as the company’s stock declined 19.82% with the market. The hedge fund run by William Leland Edwards held 310,876 shares of the commercial physical & biological resarch company at the end of 2017Q4, valued at $16.33 million, down from 433,076 at the end of the previous reported quarter. Palo Alto Investors Llc who had been investing in Exact Sciences Corp for a number of months, seems to be less bullish one the $6.26B market cap company. The stock decreased 3.04% or $1.61 during the last trading session, reaching $51.38. About 1.64 million shares traded. Exact Sciences Corporation (NASDAQ:EXAS) has risen 81.43% since May 23, 2017 and is uptrending. It has outperformed by 69.88% the S&P500.

Since January 2, 2018, it had 0 insider buys, and 21 insider sales for $25.11 million activity. Carey Thomas D. sold $335,630 worth of Exact Sciences Corporation (NASDAQ:EXAS) on Tuesday, April 10. On Friday, February 23 COWARD D SCOTT sold $187,134 worth of Exact Sciences Corporation (NASDAQ:EXAS) or 4,420 shares. $1.07M worth of Exact Sciences Corporation (NASDAQ:EXAS) was sold by Conroy Kevin T. Doyle James Edward sold $126,925 worth of stock or 3,098 shares. The insider Elliott Jeffrey Thomas sold $126,252. ARORA MANEESH sold $243,068 worth of Exact Sciences Corporation (NASDAQ:EXAS) on Monday, February 26.

More notable recent Exact Sciences Corporation (NASDAQ:EXAS) news were published by: Fool.com which released: “Don’t Get Greedy With Exact Sciences Corporation Stock” on April 25, 2018, also Gurufocus.com with their article: “Steve Mandel’s Top 5 New Buys of the 1st Quarter” published on May 22, 2018, Nasdaq.com published: “Why Exact Sciences Is Soaring Today” on April 27, 2018. More interesting news about Exact Sciences Corporation (NASDAQ:EXAS) were released by: Streetinsider.com and their article: “Lone Pine’s 13F Shows New Stake in Dollar Tree (DLTR), Square (SQ), T-Mobile (TMUS) (more…)” published on May 15, 2018 as well as Nasdaq.com‘s news article titled: “Why SVB Financial Group, Exact Sciences, and Sprint Jumped Today” with publication date: April 27, 2018.

Palo Alto Investors Llc, which manages about $1.30B and $2.32 billion US Long portfolio, upped its stake in Insmed Inc (NASDAQ:INSM) by 232,770 shares to 6.40 million shares, valued at $199.70 million in 2017Q4, according to the filing. It also increased its holding in Celgene Corp (NASDAQ:CELG) by 12,700 shares in the quarter, for a total of 307,940 shares, and has risen its stake in Amag Pharmaceuticals Inc (NASDAQ:AMAG).

Investors sentiment decreased to 0.88 in 2017 Q4. Its down 0.13, from 1.01 in 2017Q3. It dived, as 25 investors sold EXAS shares while 105 reduced holdings. 44 funds opened positions while 70 raised stakes. 92.48 million shares or 1.24% less from 93.65 million shares in 2017Q3 were reported. Eulav Asset Mgmt holds 175,000 shares. Ameriprise Fin Inc owns 118,527 shares. Goldman Sachs Grp Inc invested 0.01% in Exact Sciences Corporation (NASDAQ:EXAS). Int holds 0.01% or 79,238 shares in its portfolio. Deutsche Bank Ag holds 375,659 shares or 0.01% of its portfolio. The Massachusetts-based Acadian Asset Mgmt Ltd Liability has invested 0% in Exact Sciences Corporation (NASDAQ:EXAS). Putnam Ltd Liability owns 38,121 shares for 0% of their portfolio. Shelton Cap Mgmt holds 8,800 shares. 42,684 are owned by Royal Commercial Bank Of Canada. Fisher Asset Mgmt Ltd Liability Company invested in 6,350 shares. Financial Bank Of Montreal Can accumulated 31,254 shares or 0% of the stock. Comerica Bancorp owns 4,188 shares. Ohio-based Keybank Natl Association Oh has invested 0% in Exact Sciences Corporation (NASDAQ:EXAS). Affinity Limited Liability Corporation invested in 7,103 shares or 0.04% of the stock. 207,906 are held by Nicholas Investment Ptnrs Limited Partnership.

Analysts await Exact Sciences Corporation (NASDAQ:EXAS) to report earnings on July, 24. They expect $-0.32 EPS, down 18.52% or $0.05 from last year’s $-0.27 per share. After $-0.33 actual EPS reported by Exact Sciences Corporation for the previous quarter, Wall Street now forecasts -3.03% EPS growth.

Among 18 analysts covering EXACT Sciences (NASDAQ:EXAS), 11 have Buy rating, 1 Sell and 6 Hold. Therefore 61% are positive. EXACT Sciences had 75 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Exact Sciences Corporation (NASDAQ:EXAS) has “Hold” rating given on Tuesday, November 1 by Lake Street. The rating was upgraded by TH Capital on Wednesday, February 22 to “Buy”. The stock of Exact Sciences Corporation (NASDAQ:EXAS) earned “Neutral” rating by Roth Capital on Thursday, February 25. Jefferies maintained Exact Sciences Corporation (NASDAQ:EXAS) rating on Thursday, June 1. Jefferies has “Buy” rating and $3500 target. The stock has “Buy” rating by Jefferies on Wednesday, July 27. The rating was maintained by Lake Street on Tuesday, November 24 with “Hold”. The firm earned “Neutral” rating on Monday, November 13 by Robert W. Baird. The stock of Exact Sciences Corporation (NASDAQ:EXAS) earned “Buy” rating by Benchmark on Wednesday, January 17. The firm has “Buy” rating given on Tuesday, October 6 by Roth Capital. The stock has “Buy” rating by BTIG Research on Tuesday, April 3.

Glacier Peak Capital Llc, which manages about $202.67 million and $78.25 million US Long portfolio, upped its stake in Ashford Hospitality Prime In (NYSE:AHP) by 76,117 shares to 275,467 shares, valued at $2.68 million in 2017Q4, according to the filing. It also increased its holding in Volt Info Sciences Inc (NYSEMKT:VISI) by 142,155 shares in the quarter, for a total of 2.35M shares, and has risen its stake in Kansas City Life Ins Co.

Loral Space & Communications Inc. (NASDAQ:LORL) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *